Gentris
With Gentris Acquisition, Cancer Genetics Bolsters PGx Analysis Capabilities, Services to Pharma
Premium
Originally published June 24.
Cancer Genetics to Buy PGx Firm Gentris for up to $6.25M
NEW YORK (GenomeWeb) – Cancer Genetics today announced it has signed a non-binding letter of intent to buy Gentris for up to $6.25 million.
In Brief This Week: Bio-Rad; Fitch, Abbott; Gentris; Indiana Biosciences Research Institute; Strand Life Sciences; Oncospire Genomics
NEW YORK (GenomeWeb News) – Bio-Rad Laboratories said in its recently filed Form 10-Q that it identified errors in financial statements starting in 2008 through the second quarter of 2013 related to the valuation of finished goods inventory in the company's Life Science segment.
People in the News: Mats Svensson, David Eklund, Sara Strandberg, John Doyle, and Eric Banks
Premium
Qlucore has added three new employees to its staff.
Gentris last week expanded its genomic biomarker offering to include Affymetrix GeneChip Human Transcriptome Array services.
Jul 17, 2012
Feb 17, 2010
Pairings: Feb 17, 2010
Premium
Sep 14, 2009
Gentris Partners with Clinical Logistics
Aug 4, 2009
People in the News: Aug 4, 2009
Premium
Jul 22, 2009